Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults
Author(s) -
Ho Jun Chin,
DongWan Chae,
Yong Chul Kim,
Won Suk An,
Chun-Gyoo Ihm,
Dong Chan Jin,
Sung Gyun Kim,
Yong-Lim Kim,
YongSoo Kim,
Yoon-Goo Kim,
Hoseok Koo,
Jung Eun Lee,
Kang Wook Lee,
Jieun Oh,
Jung Hwan Park,
Hongsi Jiang,
HyunCheol Lee,
Sang Koo Lee
Publication year - 2020
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2019050546
Subject(s) - corticosteroid , medicine , tacrolimus , nephrotic syndrome , transplantation
Tacrolimus is used as a steroid-sparing immunosuppressant in adults with minimal change nephrotic syndrome. However, combined treatment with tacrolimus and low-dose steroid has not been compared with high-dose steroid for induction of clinical remission in a large-scale randomized study.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom